Who owns Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C?

The owner of Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.

How much revenue does Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C make?

SeeBITDA estimates Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C's annual revenue at about $1.5M (likely between $525K and $2.0M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.

What is Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C worth?

About $1.1M, roughly 3.3× its estimated EBITDA of $328K, typical for a doctors & clinics company its size. Likely range: $299K–$1.7M.

When was Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C founded?

Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C has been in business since 2019.

Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C

Doctors & clinics

2448 E 81st St Ste 1465, Tulsa, OK
Since 2019
NAICS 6211

Company websitestemcelltherapyrx.com Find on LinkedInSearch LinkedIn for this company

Estimated valueLow confidence

$1.1M

$299Klikely range$1.7M

About 3.3× its yearly EBITDA, typical for a company this size in its industry.

Revenue

$1.5M

a year

EBITDA

$328K

22% of revenue

Employees

—

not reported

Leadership

Owner not found yet

We haven't found the owner in public records

How we got $1.1M

Based on typical figures for its industry (2022 Economic Census), not its own records.

A typical doctors & clinics business in Oklahoma$1.5M

Revenue$1.5M

× 22% EBITDA margin$328K

× 3.3 sale multiple = value$1.1M

Own this business? Correct these figures

What we know

No PPP loan

No 401(k) filing

No reported financials

Company website

Owner not found

Compared with similar businesses nearby

Business	Est. revenue	Est. EBITDA	Distance
Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C this business	$1.5M	$328K	—
Jacob Worsham, MD Tulsa	$1.5M	$328K	0.0 mi
Dr. Jehanzeb Riaz Tulsa	$1.5M	$328K	0.0 mi
Dr. Craig Johnson Tulsa	$1.5M	$328K	0.0 mi
PREMIER ORTHOPEDIC SPECIALISTS OF TULSA, LLC Tulsa · 17 employees	$4.6M	$814K	0.0 mi
BISCHOFF HAND SURGERY, PLLC Tulsa · 3 employees	$1.1M	$239K	0.0 mi
BREAST HEALTH SPECIALISTS OF OKLAHOMA, PLLC Tulsa · 3 employees	$1.3M	$287K	0.0 mi

Ranges & sources

This business has no PPP loan on record, so there is no business-specific data. The figures are the typical estimated revenue of Offices of Physicians businesses in our Oklahoma data: the middle value, with the range covering the middle half of those businesses. EBITDA applies the industry margin (22%). Treat these as a rough guide.

Revenue range	$525K – $2.0M
EBITDA range	$113K – $421K
Industry (NAICS)	Offices of Physicians (6211)

Value range

$299K – $1.7M

EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.

Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from Overture Maps open data. Full methodology

Public records

Matched to this business by name and address from public government data; a match can occasionally be wrong.

About Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C

Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C is a doctors & clinics company in Tulsa, Oklahoma, in business since 2019. Its estimated annual revenue is about $1.5M, with roughly $328K of EBITDA. Its estimated business value is $1.1M (likely range $299K–$1.7M).

Common questions

Who owns Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C?: The owner of Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
How much revenue does Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C make?: SeeBITDA estimates Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C's annual revenue at about $1.5M (likely between $525K and $2.0M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
What is Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C worth?: About $1.1M, roughly 3.3× its estimated EBITDA of $328K, typical for a doctors & clinics company its size. Likely range: $299K–$1.7M.
When was Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C founded?: Stem Cell Therapy Rx - Nicole Forsberg APRN-C, NP-C has been in business since 2019.